CASI Pharmaceuticals (CASI) Earnings (2020 - 2025)
CASI Pharmaceuticals (CASI) earnings from Dec 31, 2020 to Dec 31, 2025. The TTM CASI Pharmaceuticals (CASI) earnings is -$48M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
CASI Pharmaceuticals (CASI) Earnings CAGR table
| Period | CAGR |
|---|---|
| 1 Year | +22.41% |
| 3 Years | +5.43% |
| 5 Years | -0.10% |
| All Time | -0.10% |
Annual Earnings change of CASI Pharmaceuticals (CASI)
| Year | Earnings | Change |
|---|---|---|
| 2025 | -$48M | +22.41% |
| 2024 | -$39M | +45.62% |
| 2023 | -$27M | -34.26% |
| 2022 | -$41M | +11.90% |
| 2021 | -$37M | -24.10% |
| 2020 | -$48M | N/A |
Comparison CASI Pharmaceuticals (CASI) five years earnings CAGR with competitors
CASI Pharmaceuticals (CASI) five years earnings CAGR is -0.10%.